Evaluation of Efficacy of Low Intensity Pulsed Ultrasound in Facilitating Mandibular Fracture Healing—A Blinded Randomized Controlled Clinical Trial

2020 ◽  
Vol 78 (6) ◽  
pp. 997.e1-997.e7
Author(s):  
Aswath Gopalan ◽  
Elavenil Panneerselvam ◽  
Guruprasad Thulasi Doss ◽  
Keerthana Ponvel ◽  
Krishnakumar Raja VB
Keyword(s):  
Clinical Trial ◽  
Fracture Healing ◽  
Mandibular Fracture ◽  
Controlled Clinical Trial ◽  
Randomized Controlled Clinical Trial ◽  
Pulsed Ultrasound ◽  
Low Intensity Pulsed Ultrasound ◽  
Low Intensity ◽  
Randomized Controlled

scholarly journals Efficacy of Low-Intensity Pulsed Ultrasound for Orthodontic Pain Control: A Randomized Clinical Trial

2021 ◽  
Author(s):  
Mohammadreza Badiee ◽  
Azita Tehranchi ◽  
Parsa Behnia ◽  
Karen Khatibzadeh
Keyword(s):  
Clinical Trial ◽  
Pain Score ◽  
Pain Control ◽  
Low Cost ◽  
Control Group ◽  
Controlled Clinical Trial ◽  
Pulsed Ultrasound ◽  
Low Intensity Pulsed Ultrasound ◽  
Low Intensity ◽  
Orthodontic Pain

Objectives: This study aimed to assess the efficacy of low-intensity pulsed ultrasound (LIPUS) for orthodontic pain control. Materials and Methods: This spilt-mouth randomized controlled clinical trial was performed on 44 mandibular first molars of 22 orthodontic patients at the Orthodontics Department of Shahid Beheshti Dental University. Elastomeric separators were placed at the mesial and distal of mandibular right and left first molars by separating pliers. Randomly, LIPUS was used at one side for 7 min and the same device with 0-degree intensity was used as sham for the other side on the facial skin. The same procedure was repeated after 24 h. Patients recorded their level of pain at 1, 6, and 24 h, and also on days 2 to 7 after, using a visual analog scale (VAS). Results: The effect of type of treatment (P=0.019), time of assessment (P<0.000) and the interaction effect of type of treatment and time of assessment (P=0.055) on the pain score were all significant. The mean pain score in the LIPUS group was significantly lower than that in the control group at 24 h (P=0.002), 4 days (P=0.031) and 5 days (P=0.035). Conclusion: LIPUS can be safely used during orthodontic treatment for pain control since it is safe, non-invasive, low-cost, and easy to use.

scholarly journals Effectiveness of a brief psychological mindfulness-based intervention for the treatment of depression in primary care: study protocol for a randomized controlled clinical trial

2019 ◽  
Vol 19 (1) ◽  
Author(s):  
Alba Lopez-Montoyo ◽  
Soledad Quero ◽  
Jesus Montero-Marin ◽  
Alberto Barcelo-Soler ◽  
Maria Beltran ◽  
...  
Keyword(s):  
Primary Care ◽  
Clinical Trial ◽  
Depressive Symptoms ◽  
Controlled Clinical Trial ◽  
Randomized Controlled Clinical Trial ◽  
Treatment As Usual ◽  
Face To Face ◽  
Low Intensity ◽  
Randomized Controlled ◽  
Treatment Of Depression

Abstract Background Depressive symptoms are quite prevalent in Primary Care (PC) settings. The treatment as usual (TAU) in PC is pharmacotherapy, despite the high relapse rates it produces. Many patients would prefer psychotherapy, but specialized services are overloaded. Studies that apply Mindfulness-Based Interventions (MBIs) for the treatment of depression have obtained significant improvements. Brief low-intensity approaches delivered from PC could be a promising approach. This study aims to compare a low-intensity mindfulness intervention for the treatment of depression in PC using different intervention formats – a face-to-face MBI delivered in a group and the same MBI individually applied on the Internet – to a control group that will receive PC medical treatment as usual. Methods A randomized controlled clinical trial will be conducted in PC, with about 120 depressed patients allocated (1:1:1) to three groups: “face-to-face MBI + TAU”, “Internet-delivered MBI + TAU”, and “TAU alone”. The MBI programs will be composed of four modules. The primary outcome will be depressive symptoms, measured through the Beck Depression Inventory, assessed at pre- and post-treatment and 6- and 12-month follow-ups. Other outcomes will be mindfulness, happiness, affectivity, quality of life, and the use of healthcare services. Intention-to-treat analysis using linear mixed models adjusted for baseline scores and routine sociodemographic analysis that could show baseline differences will be conducted. Per-protocol secondary outcome analyses will also be performed. Discussion This is the first Spanish RCT to apply a low-intensity face-to-face MBI (plus TAU) to treat depression in PC settings compared to TAU (alone). Moreover, this study will also make it possible to evaluate the same MBI program (plus TAU), but Internet-delivered, considering their cost-effectiveness. Positive results from this RCT might have an important impact on mental health settings, helping to decrease the overload of the system and offering treatment alternatives beyond antidepressant medication through high-quality, flexible PC interventions. Trial registration Clinical Trials.gov NCT03034343. Trial Registration date 24 January 2017, retrospectively registered.

Comparision of two fluoride varnishes for controlling white spot lesions. Randomized clinical trial

2017 ◽  
Vol 16 (1) ◽  
Author(s):  
Jesús Alberto Luengo - Fereira
Keyword(s):  
Clinical Trial ◽  
Randomized Clinical Trial ◽  
White Spot ◽  
Controlled Clinical Trial ◽  
White Spot Lesions ◽  
Randomized Controlled Clinical Trial ◽  
Chi Square ◽  
Randomized Controlled ◽  
Anterior Teeth ◽  
The Mean

Objective: To compare two fluorinated varnishes for the control of white spot lesions.Material and Methods: A randomized controlled clinical trial was conducted. A total of 103 active whitespot lesions on permanent upper anterior teeth from 24 patients, aged 7 to 9 years were randomly assigned totwo groups, G1: Duraphat® (n=52) and G2: DuraShield® (n=51). Weekly applications were perform for fourconsecutive weeks. Fifth week the dimension, regression and activity of the lesions were evaluated. Student’sT test, Wilcoxon Ranks and Chi square were used at 5% significance. Results: At the end of the study, the lesion reduction was observed in 69.7%, finding significant differences(p<0.05) in the mean of the initial and final dimensions in general (2.74 mm to 1.91 mm) and in each group, G1(2.84 mm to 2.03 mm), G2 (2.64 mm to 1.78 mm). In the activity of the lesions, it was found in the G1, 12 active and6 inactive lesions; while in G2, there were 14 active and 29 inactive; these differences were significant (p<0.05). Conclusions: The two evaluated products showed similar clinical efficacy in the remineralization of activewhite spot lesions after 4 weeks of therapy.

Sign in / Sign up

Export Citation Format

Share Document